Insulet Corporation (PODD)
Last updated: 2026-10-21 23:47:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Insulet Corporation (PODD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $141.90, with a market capitalization of $9.85B and a P/E ratio of 26.36. Over the past 52 weeks, its price has ranged from $126.40 to $354.88. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$9.85B | |
$141.59 | |
$354.88 | |
$2.57 | |
$142.64 | |
668.87K | |
1.71M | |
26.36 | |
$354.88 | |
$126.40 | |
-- | |
-- |
Insulet Corporation (PODD) After-Hours Stock Price
Insulet Corporation (PODD) is trading at $140.40 in after-hours trading as of 2026-10-21 23:31:00, down 1.57% ($2.24) from the regular-session close of $142.64.
After-hours trading shows how investors are pricing PODD after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Insulet Corporation (PODD) 7-Day Stock Price Change
Over the past seven days, Insulet Corporation (PODD) moved from $139.81 to $141.90, representing a gain of 1.50% ($2.09).
The stock traded between $133.58 and $146.47 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.67 million shares, down versus the previous seven-day period, indicating lower trading activity.
PODD 52-Week Price Position
Position in Range: 6.8%
PODD is currently trading at $141.90, placing it 6.8% of the way from its 52-week low of $126.40 to its 52-week high of $354.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Insulet Corporation (PODD)?
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Insulet Corporation Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 5400 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Insulet Corporation (PODD) Stock on MEXC
Eligible investors can buy real shares of Insulet Corporation (PODD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Insulet Corporation (PODD) stock price today?
2.Is PODD stock going up or down today?
3.What is PODD pre-market price?
4.What is PODD after-hours price?
5.Is PODD stock trading now?
6.Where does PODD sit relative to its 52-week high and low?
7.What sector is Insulet Corporation in?
8.What is Insulet Corporation's market capitalization and where is it listed?
9.How is PODD valued in terms of P/E ratio and EPS?
10.Does Insulet Corporation pay a dividend?
Explore More US Stocks
Search Stocks
PODD Stock Calculator
Estimate the value between PODD shares and USD.
PODD Shares to USD
1.00 PODD shares = 141.904 USD
Calculations are estimates based on the latest available price and are for reference only.


